EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit

NEW YORK, Feb. 16, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025…